Company Overview
Snapshot
Founded in June 2021, Pulsar Medtech operates with 1–10 employees. The company has secured funding across one round from one investor. In June 2024, Pulsar Medtech received Seed funding from Iron Nation.
Business overview
Pulsar Medtech is transforming the orthopedic sector by developing wearable bone growth stimulators. The company's core technology involves small, smart, and wearable electronic patches designed to replace traditional, bulky devices. Its flagship product, the Fracture Healing Patch (FHP), aims to improve patient compliance and accelerate bone healing for non-union fractures and other orthopedic conditions. Pulsar Medtech operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving patients and providers in the North American geomarket.
Log in to access full profile ›Company Intelligence Q&A
- What is Pulsar Medtech's primary product?
- Pulsar Medtech's flagship product is the Fracture Healing Patch (FHP), a smart, wearable electronic patch designed to stimulate bone growth and accelerate healing for various orthopedic conditions.
- When was Pulsar Medtech founded?
- Pulsar Medtech was founded in June 2021.
- What is the company's employee count?
- Pulsar Medtech currently has 1–10 employees.
- Which investor participated in Pulsar Medtech's funding round?
- In June 2024, Pulsar Medtech received Seed funding from Iron Nation.
- What problem does Pulsar Medtech aim to solve?
- Pulsar Medtech aims to address the issue of poor patient compliance with traditional, bulky bone growth stimulator devices by offering a comfortable, discreet, and wearable alternative that integrates seamlessly into a patient's lifestyle.